Examines trends in metabolic bariatric surgery utilization amidst glucagon-like peptide-1 advancements, indicating shifts in treatment approaches.
This study examines trends in metabolic bariatric surgery utilization in the era of glucagon-like peptide-1 receptor agonists.
No takes yet. Share an insight, caveat, or question.
Calzaretta et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: